Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Mayo Clinic to deploy and test Microsoft generative AI tools

    September 29, 2023

    Mylab Discovery Solutions introduces MyNeoShield for NBS

    September 28, 2023

    Celebrating World Pharmacists Day: Honoring unsung healthcare heroes

    September 27, 2023
    Facebook Twitter Instagram
    Your Healthtech
    • Health

      Mayo Clinic to deploy and test Microsoft generative AI tools

      September 29, 2023

      Mylab Discovery Solutions introduces MyNeoShield for NBS

      September 28, 2023

      Celebrating World Pharmacists Day: Honoring unsung healthcare heroes

      September 27, 2023

      Fortis Healthcare gains on plans to acquire Kolkata-based realty firm

      September 26, 2023

      Johnson & Johnson Vision introduces new procedure for patients with myopia

      September 25, 2023
    Your Healthtech
    Home»Health»Allurion Technologies Announces New Data on the Impact of the Allurion Program on Type 2 Diabetes and Prediabetes
    Health

    Allurion Technologies Announces New Data on the Impact of the Allurion Program on Type 2 Diabetes and Prediabetes

    yourhealthtechBy yourhealthtechMarch 10, 2022No Comments7 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Program prompts abatement of Type 2 Diabetes with decrease in normal hemoglobin A1c of 1.5% joined with normal Total Body Weight Loss of 16.2% after only 4 months

     Allurion Technologies, an organization committed to finishing heftiness, today reported new clinical information on the Allurion Program introduced at ObesityWeek® 2021. The Allurion Program is a 360-degree weight reduction experience highlighting the Allurion Balloon, the world’s solitary swallowable, procedureless gastric inflatable for weight reduction, far off understanding observing through the Allurion Virtual Care Suite including the Allurion Connected Scale, Health Tracker, and App, and Allurion Insights, a supplier entrance that empowers message, telehealth, and start to finish patient administration.

    “Current medicines for weight and diabetes either experience the ill effects of helpless security and viability or a helpless patient encounter. The Allurion Program offers a convincing option for the treatment of both of these conditions.” Tweet this In spite of the accessibility of pharmacologic treatments for Type 2 Diabetes, the occurrence of metabolic sickness keeps on ascending all throughout the planet. As per the International Diabetes Federation, 537 million grown-ups are presently living with diabetes around the world, an expansion of 16% (74 million individuals) starting around 2019. By 2045, 783 million individuals—or 1 out of 8 grown-ups—will be living with diabetes around the world, showing that current treatment choices are not adequate. “Corpulence and Type 2 Diabetes are pandemics of exceptional extent, and they frequently distress patients at the same time,” said Dr. Shantanu Gaur, fellow benefactor and CEO of Allurion. “Current medicines for corpulence and diabetes either experience the ill effects of helpless security and adequacy or a helpless patient encounter. The Allurion Program offers a convincing option for the treatment of both of these conditions.” In a theoretical submitted and acknowledged for show at ObesityWeek 2021 named Allurion Gastric Balloon Program is an Emerging Novel Treatment for Type 2 Diabetes and Prediabetes, Dr. Roberta Ienca and associates report on 226 patients (78 with Type 2 Diabetes and 148 with prediabetes) who took a crack at the Allurion Program and were followed for a time of 4 months. Following 4 months, mean hemoglobin A1c (HbA1c) diminished from 7.0% to 5.5% with a mean weight reduction of 19.3kg in patients with diabetes. Reduction of diabetes is ordinarily characterized as bringing HbA1c down to underneath 6.5%, demonstrating that the normal patient in the diabetes bunch accomplished abatement after only 4 months.

    Chief Medical Officer of Allurion. “These outcomes highlight the advantages of the Allurion Program past weight reduction and feature how rapidly the Allurion Program can affect patients with Type 2 Diabetes or prediabetes.” About Allurion Technologies Allurion Technologies is devoted to finishing stoutness. The Allurion Program is a 360-degree weight reduction experience highlighting the Allurion Gastric Balloon, the world’s sole swallowable, procedureless gastric inflatable for weight reduction, the Allurion Virtual Care Suite

     Become familiar with Allurion online at www.allurion.com. Allurion is a brand name of Allurion Technologies, Inc. in the United States and nations all throughout the planet.

    Allurion Technologies Announces New Data on the Impact of the Allurion Program on Type 2 Diabetes and Prediabetes

    Development in the worldwide is set to be energized by rising worldwide commonness of persistent irresistible infections, expanding sanitation concerns, developing requirement for quick and simple analysis, rising public-private ventures, subsidizing, and research gives, and supported mechanical progressions.

    Proceeded with mechanical progressions as far as further developed usefulness, effectiveness, viability, quicker outcomes, and exactness are driving the reception of microbial testing in scholarly establishments, research labs, medical clinics, clinical labs, and biotechnology and drug organizations.

    Fast progressions in microbial testing help in beating restrictions, for example, a broad time of openness to pathogenic strains and long procedural occasions related with customary testing techniques. Also, these tests fill in as a practical option in contrast to microbial distinguishing proof by empowering decrease in the consumable expense per technique.

    Key Topics Covered:

    I. System

    II. Leader SUMMARY

    1. MARKET OVERVIEW

    Effect of COVID-19 Pandemic and Looming Global Recession

    Clinical Microbiology Gains Prominence as Scientists Mobilize United Efforts to Find Ways to Detect, Treat and Vaccinate People Against the Novel Coronavirus: COVID-19 Tests Per Million Population by Country (As of 15 June 2021)

    1. A New, 20-Minute Assay for COVID-19 Diagnosis
    2. Mechanized and Rapid Microbiological Tests: An Introduction
    3. Empowering Technologies of Automated and Rapid Microbiological Tests
    4. Clinical Applications of Automated and Rapid Microbiological Tests
    5. Applications in Non-Clinical Investigations
    6. Worldwide Market Prospects and Outlook
    7. Developmental Battle against Microbes Drives Market Future
    8. Clinical Applications Lead the Global Market for Automated and Rapid Microbiological Testing
    9. Created Regions Lead, Developing Economies to Boost Future Growth
    10. Rivalry
    11. Late Market Activity

    2. Zero in ON SELECT PLAYERS (Total 77 Featured)

    1. Abbott Laboratories
    2. Abbott Molecular, Inc.
    3. Aidian Oy
    4. Beckman Coulter, Inc.
    5. Becton Dickinson and Company
    6. bioMerieux SA
    7. bioMerieux, Inc.
    8. Bio-Rad Laboratories, Inc
    9. Cellabs Pty Ltd
    10. Cepheid Inc.
    11. CorisBioconcept SPRL
    12. F. Hoffmann-La Roche AG
    13. Hologic, Inc.
    14. MedMira Inc.
    15. Meridian Bioscience, Inc.
    16. OraSure Technologies, Inc.
    17. Oxoid Limited
    18. QIAGEN N.V.
    19. Quidel Corporation
    20. Fast Micro Biosystems, Inc.
    21. Sekisui Diagnostics, LLC
    22. Siemens Healthcare GmbH
    23. Thermo Fisher Scientific Inc.

    3. MARKET TRENDS and DRIVERS

    1. Fast Diagnostics Bring in a Transformation to Clinical Testing Practices
    2. Customary Rapid Microbiological Tests Make Way for New, Probe Tests
    3. Lab Automation Trend Augurs Well for Microbiological Testing Labs
    4. Customary Approaches Give Way to Modern Automated Microbiology Systems
    5. Microbial science Laboratories Switch to Automation to Push Yields
    6. Developing Incidence of Infectious Diseases to Fuel Demand for Rapid Microbiology Testing
    7. Rising Prevalence of Respiratory Infections Drive Market Growth
    8. Ascend in Prevalence of COPD Augments Demand
    9. Flu Boosts Rapid Test Prospects
    10. Ascend in Pollution Levels Trigger Increase in Respiratory Diseases, Driving Opportunities for Automated Microbiology Tests
    11. Supported Threat of HIV and Sexually Transmitted Diseases Amplify Need for Rapid Microbiological Testing
    12. Fast HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
    13. Home HIV Testing Emerges as a Lucrative Option
    14. Headways in Molecular Diagnostics Drive Market Growth
    15. Arising Technologies in Clinical Microbiology Diagnostics Aim at Faster Diagnosis
    16. Robotized Blood Culture Systems: The Gold Standard in the Fight against Bacteremia
    17. Headways in Molecular Diagnostics: A Boon for Rapid Microbiological Testing Market
    18. Biotechnology: A Crucial Step Ahead in the Growing Popularity of Rapid Microbial Tests
    19. Medical services Needs of the World’s Aging Population: Potential Opportunity in Store
    20. Expansion in Healthcare Spending in Emerging Markets to Propel Demand for Automated Microbiological Testing
    21. Clinical Microbiology Market Benefits from Digitalization and Robotization Trend
    22. Reconciliation of Clinical Microbiology with Cloud Computing
    23. Computerized reasoning Holds Positive Implications for Automation of Clinical Microbiology
    24. Reason behind Care Rapid Microbiological Testing: Yet to Realize Its Full Potential.
    25. Mechanical Advancements to Drive the Automated Microbiology Testing Market
    26. Zero in on Safe and High-Quality Foods Propels Rapid Microbiological Testing
    27. Foodborne Illness Outbreak Investigations in the US (2019 and 2020)
    28. Effect of COVID-19 on Food Safety Testing Industry
    29. Tough Norms Necessitate Food Safety Testing
    30. Food Microbiology Testing Market on a Growth Spree
    31. Fast and Automated Tests Emerge as an Attractive Solution
    32. Driving Food Processors Exhibit Inclination Towards Rapid Microbiological Testing
    33. Robotization of Food Microbiology Labs
    34. Poultry Industry Embraces Rapid Microbiological Testing Technologies
    35. Fast Microbial Testing in Dairy Industry
    36. Constant PCR/qPCR Technologies Fundamental in Food Safety Testing
    37. Specialized and Cost Related Hurdles Hamper the Microbiology Testing Market
    38. Fast Microbiological Testing Gains Significance in the Pharmaceutical Industry
    39. Key Advantages of Rapid Microbiological Tests for Pharmaceutical Industry
    40. Developing Importance of Rapid Microbiological Testing for Pharma Laboratories
    41. Key RMM Technologies for Pharmaceutical Industry
    42. Reception of Rapid Methods for QC Microbiology in Biopharmaceuticals
    43. Progressions in Rapid Microbiological Testing for Pharmaceutical Industry
    44. Quick Microbial Testing for Regenerative Medicine: An Emerging Space
    45. Quick Microbiological Methods and the Regulatory Environment in Drug Development Industry
    46. FDA’s Requirements for Validation of RMM
    47. EMA’s Guidance on Use of RMMs for Water Testing
    48. Quick Microbial Testing Emerges as an Important Means for Quality Control of Advanced Therapies
    49. Anti-microbial Resistant Bacteria Throws the Spotlight on Rapid Microbial Testing Tools
    50. Antimicrobial Vulnerability Testing and Identification of Microbial strains
    51. Job of Microscopy in Antimicrobial Susceptibility Testing
    52. Rising Prominence of NAAT-Driven AST
    53. Financial Factors Promise Growth for Rapid AST
    54. Quick Technologies Gain Momentum in Environment Testing Field
    55. Crumbling Quality of Water Throws Emphasis on Water Testing Services
    56. Central questions Confronting the Rapid Microbiological Tests Market
    57. 4. Worldwide MARKET PERSPECTIVE
    58. III. Local MARKET ANALYSIS
    59. IV. Rivalry
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleCorval™ Launches New Biopharma Commercialization Planning Platform
    Next Article Enters Into Multi-target License and Collaboration Agreement With Regeneron to Develop Innovative Vaccines Against Cancer and Infectious Diseases
    yourhealthtech
    • Website

    Related Posts

    Mayo Clinic to deploy and test Microsoft generative AI tools

    September 29, 2023

    Mylab Discovery Solutions introduces MyNeoShield for NBS

    September 28, 2023

    Celebrating World Pharmacists Day: Honoring unsung healthcare heroes

    September 27, 2023

    Fortis Healthcare gains on plans to acquire Kolkata-based realty firm

    September 26, 2023

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fintech
    • Your Revenue
    • Your Bio Tech
    • Your Info Tech
    • Your POS Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.